Due to its broad binding repertoire, including ECM constituents, multiple growth factors and receptor tyrosine kinases, decorin holds a multifaceted role in cancer and has been considered “a guardian from the matrix”, as it attenuates paracrine signals that would otherwise facilitate malignant transformation [35,73]. The gene discussed is DCN; the disease is cancer.